Clinical Trials in Massachusetts

Showing 6701-6720 of 17,868 trials

Expanded Access Protocol: Repeated Administration of Nurown® (Autologous MSC-NTF Cells) for the Treatment of ALS

NCT04681118

Expanded Access for treatment with investigational product MSC-NTF cells(NurOwn®) for participants who completed all scheduled treatments and follow-up assessments in the BCT-002-US study

Amyotrophic Lateral Sclerosis

Brainstorm-Cell Therapeutics

Irvine, California, United States • San Francisco, California, United States • Boston, Massachusetts, United States +2 more locations

COMPLETEDNA14 miles

The TESLA Trial: Thrombectomy for Emergent Salvage of Large Anterior Circulation Ischemic Stroke

NCT03805308

The primary objective of the trial is to establish the effectiveness of IAT (versus medical management) in patients with moderate-large infarcts (NCCT ASPECTS 2-5) at baseline, with adaptive enrichment to better define the upper limit of infarct volume for treatment eligibility. Furthermore, the investigators aim to determine whether certain subgroups of patients with large baseline infarcts will have a greater treatment benefit. Finally, the investigators will assess the agreement of ASPECTS scores between site investigators, the core imaging lab, and automated software.

Ischemic Stroke

Mercy Health Ohio300 participantsStarted Jul 2019

Little Rock, Arkansas, United States • Los Angeles, California, United States • Pomona, California, United States +40 more locations

Expanded Access Protocol: Repeated Administration of Nurown® (Autologous MSC-NTF Cells) for the Treatment of ALS

The TESLA Trial: Thrombectomy for Emergent Salvage of Large Anterior Circulation Ischemic Stroke

Find Trials by Condition in Massachusetts

A Study Evaluating JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing in Adult Participants ≥ 22 Years Old

Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease

Relationship Between Strain and Stroke Volume in Cardiac Surgery

A Study of Intraperitoneally Administered AVB-001 in Patients With Serous Adenocarcinoma of the Ovary

PH 1 Biomarker Study of Nivolumab and Ipilimumab and Nivolumab in Combination With Ipilimumab in Advanced Melanoma

Effect of Acupuncture and Pain Medication on Radicular Pain Using QST

Pilot Testing an Innovative Physical Activity Intervention for Parents Attending Their Children's Sport Practices

A Clinical Study Comparing the Comfort of Three Commercially Available Contact Lenses

Recent-Onset Type 1 Diabetes Trial Evaluating Efficacy and Safety of Teplizumab

Mogamulizumab Q4week Dosing in Participants With R/R CTCL

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Risdiplam (RO7034067) in Type 2 and 3 Spinal Muscular Atrophy (SMA) Participants

Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities

Craniofacial Microsomia: Accelerating Understanding of the Significance and Etiology

Efficacy and Safety of S95011 in Primary Sjögren's Syndrome Patients

The Effect of Intrawound Vancomycin Powder in Spine Surgery

KHK2455 Alone and in Combination With Mogamulizumab in Subjects With Locally Advanced or Metastatic Solid Tumors

A Trial to Evaluate the Effect of Food on LEO 152020

A Study Of PF-04449913 In Select Hematologic Malignancies